Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'Kamataki, T' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 145 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Fujita, K; Kamataki, T
      Role of human cytochrome P450 (CYP) in the metabolic activation of N-alkylnitrosamines: application of genetically engineered Salmonella typhimurium YG7108 expressing each form of CYP together with human NADPH-cytochrome P450 reductase

      MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
    2. Muto, S; Fujita, K; Yamazaki, Y; Kamataki, T
      Inhibition by green tea catechins of metabolic activation of procarcinogens by human cytochrome P450

      MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
    3. Loriot, MA; Rebuissou, S; Oscarson, M; Cenee, S; Miyamoto, M; Ariyoshi, N; Kamataki, T; Hemon, D; Beaune, P; Stucker, I
      Genetic polymorphisms of cytochrome P450 2A6 in a case-control study on lung cancer in a French population

      PHARMACOGENETICS
    4. Mushiroda, T; Ariyoshi, N; Yokoi, T; Takahara, E; Nagata, O; Kato, H; Kamataki, T
      Accumulation of the 1-methyl-4-phenylpyridinium ion in suncus (Suncus murinus) brain: Implication for flavin-containing monooxygenase activity in brain microvessels

      CHEMICAL RESEARCH IN TOXICOLOGY
    5. Takahashi, Y; Kamataki, T
      Competitive inhibition of the transcription of rabbit CYP1A1 gene by upstream stimulatory factor 1 (USF1)

      DRUG METABOLISM REVIEWS
    6. Murata, M; Watanabe, M; Yamanaka, M; Kubota, Y; Ito, H; Nagao, M; Katoh, T; Kamataki, T; Kawamura, J; Yatani, R; Shiraishi, T
      Genetic polymorphisms in cytochrome P450 (CYP) 1A1, CYP1A2, CYP2E1, glutathione S-transferase (GST) M1 and GSTT1 and susceptibility to prostate cancer in the Japanese population

      CANCER LETTERS
    7. Ozeki, T; Takahashi, Y; Kume, T; Nakayama, K; Yokoi, T; Nunoya, K; Hara, A; Kamataki, T
      Co-operative regulation of the transcription of human dihydrodiol dehydrogenase (DD)4/aldo-keto reductase (AKR)1C4 gene by hepatocyte nuclear factor (HNF)-4 alpha/gamma and HNF-1 alpha

      BIOCHEMICAL JOURNAL
    8. Fujita, K; Kamataki, T
      Screening of organosulfur compounds as inhibitors of human CYP2A6

      DRUG METABOLISM AND DISPOSITION
    9. Hashizume, T; Mise, M; Matsumoto, S; Terauchi, Y; Fujii, T; Imaoka, S; Funae, Y; Kamataki, T; Miyazaki, H
      A novel cytochrome P450 enzyme responsible for the metabolism of ebastine in monkey small intestine

      DRUG METABOLISM AND DISPOSITION
    10. Saito, T; Takahashi, Y; Hashimoto, H; Kamataki, T
      Novel transcriptional regulation of the human CYP3A7 gene by Sp1 and Sp3 through nuclear factor kappa B-like element

      JOURNAL OF BIOLOGICAL CHEMISTRY
    11. Baker, JR; Satarug, S; Reilly, PEB; Edwards, RJ; Ariyoshi, N; Kamataki, T; Moore, MR; Williams, DJ
      Relationships between non-occupational cadmium exposure and expression of nine cytochrome P450 forms in human liver and kidney cortex samples

      BIOCHEMICAL PHARMACOLOGY
    12. Nakayama, K; Sudo, Y; Sasaki, Y; Iwata, H; Takahashi, M; Kamataki, T
      Studies on transcriptional regulation of Cyp3a16 gene in mouse livers by application of direct DNA injection method

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    13. Nukaya, M; Takahashi, Y; Gonzalez, FJ; Kamataki, T
      Aryl hydrocarbon receptor-mediated suppression of expression of the low-molecular-weight prekininogen gene in mice

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    14. Iwano, S; Saito, T; Takahashi, Y; Fujita, K; Kamataki, T
      Cooperative regulation of CYP3A5 gene transcription by NF-Y and Sp family members

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    15. Imaoka, S; Hayashi, K; Hiroi, T; Yabusaki, Y; Kamataki, T; Funae, Y
      A transgenic mouse expressing human CYP4B1 in the liver

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    16. Ariyoshi, N; Miyazaki, M; Toide, K; Sawamura, Y; Kamataki, T
      A single nucleotide polymorphism of CYP2B6 found in Japanese enhances catalytic activity by autoactivation

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    17. Ariyoshi, N; Sawamura, Y; Kamataki, T
      A novel single nucleotide polymorphism altering stability and activity of CYP2A6

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    18. Hashizume, T; Imaoka, S; Hiroi, T; Terauchi, Y; Fujii, T; Miyazaki, H; Kamataki, T; Funae, Y
      cDNA cloning and expression of a novel cytochrome P450 (CYP4F12) from human small intestine

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    19. Kushida, H; Fujita, K; Suzuki, A; Yamada, M; Nohmi, T; Kamataki, T
      Development of a Salmonella tester strain sensitive to promutagenic N-nitrosamines: expression of recombinant CYP2A6 and human NADPH-cytochrome P450 reductase in S-typhimurium YG7108

      MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS
    20. Mushiroda, T; Yokoi, T; Itoh, K; Nunoya, K; Nakagawa, T; Kubota, M; Takahara, E; Nagata, O; Kato, H; Kamataki, T
      The house musk shrew (Suncus murinus): a unique animal with extremely low level of expression of mRNAs for CYP3A and flavin-containing monooxygenase

      COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-PHARMACOLOGY TOXICOLOGY & ENDOCRINOLOGY
    21. Ariyoshi, N; Takahashi, Y; Miyamoto, M; Umetsu, Y; Daigo, S; Tateishi, T; Kobayashi, S; Mizorogi, Y; Loriot, MA; Stucker, I; Beaune, P; Kinoshita, M; Kamataki, T
      Structural characterization of a new variant of the CYP2A6 gene (CYP2A6*1B) apparently diagnosed as heterozygotes of CYP2A6*1A and CYP2A6*4C

      PHARMACOGENETICS
    22. Kushida, H; Fujita, K; Suzuki, A; Yamada, M; Endo, T; Nohmi, T; Kamataki, T
      Metabolic activation of N-alkylnitrosamines in genetically engineered Salmonella typhimurium expressing CYP2E1 or CYP2A6 together with human NADPH-cytochrome P450 reductase

      CARCINOGENESIS
    23. Schuetz, EG; Schmid, W; Schutz, G; Brimer, C; Yasuda, K; Kamataki, T; Bornheim, L; Myles, K; Cole, TJ
      The glucocorticoid receptor is essential for induction of cytochrome P-4502B by steroids but not for drug or steroid induction of CYP3A or P-450 reductase in mouse liver

      DRUG METABOLISM AND DISPOSITION
    24. Mushiroda, T; Yokoi, T; Takahara, E; Nagata, O; Kato, H; Kamataki, T
      The suncus (Suncus murinus) shows poor metabolic phenotype for trimethylamine N-oxygenation

      TOXICOLOGY AND APPLIED PHARMACOLOGY
    25. Fujita, K; Mogami, A; Hayashi, A; Kamataki, T
      Establishment of Salmonella strain expressing catalytically active human UDP-glucuronosyltransferase 1A1 (UGT1A1)

      LIFE SCIENCES
    26. Mushiroda, T; Ariyoshi, N; Kimura, K; Takahara, E; Nagata, O; Kato, H; Kamataki, T
      A high-level expression of CYP2A in the lung of the suncus (Suncus murinus) and its role in the activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    27. Inoue, E; Takahashi, Y; Imai, Y; Kamataki, T
      Development of bacterial expression system with high yield of CYP3A7, a human fetus-specific form of cytochrome P450

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    28. Satoh, T; Fujita, K; Munakata, H; Itoh, S; Nakamura, K; Kamataki, T; Itoh, S; Yoshizawa, I
      Studies on the interactions between drugs and estrogen: Analytical method for prediction system of gynecomastia induced by drugs on the inhibitory metabolism of estradiol using Escherichia coli coexpressing human CYP3A4 withhuman NADPH-cytochrome P450 reductase

      ANALYTICAL BIOCHEMISTRY
    29. Mushiroda, T; Yokoi, T; Takahara, E; Nagata, O; Kato, H; Kamataki, T
      Sensitive assay of trimethylamine N-oxide in liver microsomes by headspacegas chromatography with flame thermionic detection

      JOURNAL OF CHROMATOGRAPHY B
    30. Kamataki, T; Nunoya, K; Sakai, Y; Kushida, H; Fujita, K
      Genetic polymorphism of CYP2A6 in relation to cancer

      MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
    31. Marczylo, TH; Hayatsu, T; Arimoto-Kobayashi, S; Tada, M; Fujita, K; Kamataki, T; Nakayama, K; Hayatsu, H
      Protection against the bacterial mutagenicity of heterocyclic amines by purpurin, a natural anthraquinone pigment

      MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS
    32. Kume, T; Iwasa, H; Shiraishi, H; Yokoi, T; Nagashima, K; Otsuka, M; Terada, T; Takagi, T; Hara, A; Kamataki, T
      Characterization of a novel variant (S145C/L311V) of 3 alpha-hydroxysteroid/dihydrodiol dehydrogenase in human liver

      PHARMACOGENETICS
    33. Chida, M; Yokoi, T; Kosaka, Y; Chiba, K; Nakamura, H; Ishizaki, T; Yokota, J; Kinoshita, M; Sato, K; Inaba, M; Aoki, Y; Gonzalez, FJ; Kamataki, T
      Genetic polymorphism of CYP2D6 in the Japanese population

      PHARMACOGENETICS
    34. Chida, M; Yokoi, T; Nemoto, N; Inaba, M; Kinoshita, M; Kamataki, T
      A new variant CYP2D6 allele (CYP2D6*21) with a single base insertion in exon 5 in a Japanese population associated with a poor metabolizer phenotype

      PHARMACOGENETICS
    35. Chida, M; Yokoi, T; Fukui, T; Kinoshita, M; Yokota, J; Kamataki, T
      Detection of three genetic polymorphisms in the 5 '-flanking region and intron 1 of human CYP1A2 in the Japanese population

      JAPANESE JOURNAL OF CANCER RESEARCH
    36. Kamataki, T; Suzuki, A; Kushida, H; Iwata, H; Watanabe, M; Nohmi, T; Fujita, K
      Establishment of a Salmonella tester strain highly sensitive to mutagenic heterocyclic amines

      CANCER LETTERS
    37. Muto, S; Yokoi, T; Gondo, Y; Katsuki, M; Shioyama, Y; Fujita, K; Kamataki, T
      Inhibition of benzo[a]pyrene-induced mutagenesis by (-)-epigallocatechin gallate in the lung of rpsL transgenic mice

      CARCINOGENESIS
    38. Kashiyama, E; Yokoi, T; Odomi, M; Kamataki, T
      Stereoselective S-oxidation and reduction of flosequinan in rat

      XENOBIOTICA
    39. Nunoya, K; Yokoi, T; Kimura, K; Kainuma, T; Satoh, K; Kinoshita, M; Kamataki, T
      A new CYP2A6 gene deletion responsible for the in vivo polymorphic metabolism of (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride inhumans

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    40. Sasaki, Y; Takahashi, Y; Nakayama, K; Kamataki, T
      Cooperative regulation of CYP2C12 gene expression by STAT5 and liver-specific factors in female rats

      JOURNAL OF BIOLOGICAL CHEMISTRY
    41. Nunoya, K; Yokoi, T; Takahashi, Y; Kimura, K; Kinoshita, M; Kamataki, T
      Homologous unequal cross-over within the human CYP2A gene cluster as a mechanism for the deletion of the entire CYP2A6 gene associated with the poor metabolizer phenotype

      JOURNAL OF BIOCHEMISTRY
    42. Nakajima, M; Yokoi, T; Mizutani, M; Kinoshita, M; Funayama, M; Kamataki, T
      Genetic polymorphism in the 5 '-flanking region of human CYP1A2 gene: Effect on the CYP1A2 inducibility in humans

      JOURNAL OF BIOCHEMISTRY
    43. Tateishi, T; Chida, M; Ariyoshi, N; Mizorogi, Y; Kamataki, T; Kobayashi, S
      Analysis of the CYP2D6 gene in relation to dextromethorphan O-demethylation capacity in a Japanese population (vol 65, pg 570, 1999)

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    44. Tateishi, T; Chida, M; Ariyoshi, N; Mizorogi, Y; Kamataki, T; Kobayashi, S
      Analysis of the C Upsilon P2D6 gene in relation to dextromethorphan O-demethylation capacity in a Japanese population

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    45. Miyamoto, M; Umetsu, Y; Dosaka-Akita, H; Sawamura, Y; Yokota, J; Kunitoh, H; Nemoto, N; Sato, K; Ariyoshi, N; Kamataki, T
      CYP2A6 gene deletion reduces susceptibility to lung cancer

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    46. TANI H; OOURA T; KAMIDATE T; KAMATAKI T; WATANABE H
      SEPARATION OF MICROSOMAL CYTOCHROME B(5) VIA PHASE-SEPARATION IN A MIXED-SOLUTION OF TRITON X-114 AND CHARGED DEXTRAN

      Journal of chromatography B. Biomedical sciences and applications
    47. SAWADA M; KAMATAKI T
      GENETICALLY-ENGINEERED CELLS STABLY EXPRESSING CYTOCHROME-P450 AND THEIR APPLICATION TO MUTAGEN ASSAYS

      Mutation research. Reviews in mutation research
    48. MORI T; ITOH S; KAMATAKI T
      MOLECULAR-CLONING AND REGULATION OF A NOVEL GUINEA-PIG CYTOCHROME-P450 (CYP3A20) WHICH DIFFERS FROM GUINEA-PIG CYP3A14 IN ONLY 2 AMINO-ACID-RESIDUES

      Biochemistry and molecular biology international
    49. ANDO Y; CHIDA M; NAKAYAMA K; SAKA H; KAMATAKI T
      THE UGT1A1-ASTERISK-28 ALLELE IS RELATIVELY RARE IN A JAPANESE POPULATION

      Pharmacogenetics
    50. NUNOYA K; YOKOI T; KIMURA K; INOUE K; KODAMA T; FUNAYAMA M; NAGASHIMA K; FUNAE Y; GREEN C; KINOSHITA M; KAMATAKI T
      A NEW DELETED ALLELE IN THE HUMAN CYTOCHROME-P450 2A6 (CYP2A6) GENE FOUND IN INDIVIDUALS SHOWING POOR METABOLIC CAPACITY TO COUMARIN AND (-CIS-3,5-DIMETHYL-2-(3-PYRIDYL)THIAZOLIDIN-4-ONE HYDROCHLORIDE (SM-12502)())

      Pharmacogenetics
    51. ANDO Y; SAKA H; ASAI G; SUGIURA S; SHIMOKATA K; KAMATAKI T
      UGT1A1 GENOTYPES AND GLUCURONIDATION OF SN-38, THE ACTIVE METABOLITE OF IRINOTECAN

      Annals of oncology
    52. YOKOI T; KAMATAKI T
      GENETIC-POLYMORPHISM OF DRUG-METABOLIZING-ENZYMES - NEW MUTATIONS IN CYP2D6 AND CYP2A6 GENES IN JAPANESE

      Pharmaceutical research
    53. TAKASUNA K; HAGIWARA T; HIROHASHI M; KATO M; NOMURA M; NAGAI E; YOKOI T; KAMATAKI T
      INHIBITION OF INTESTINAL MICROFLORA BETA-GLUCURONIDASE MODIFIES THE DISTRIBUTION OF THE ACTIVE METABOLITE OF THE ANTITUMOR AGENT, IRINOTECAN HYDROCHLORIDE (CPT-11) IN RATS

      Cancer chemotherapy and pharmacology
    54. KAMATAKI T; YOKOI T; FUJITA K; ANDO Y
      PRECLINICAL APPROACH FOR IDENTIFYING DRUG-INTERACTIONS

      Cancer chemotherapy and pharmacology
    55. Kondo, Y; Abbott, ST; Kitamura, A; Kamp, PJJ; Naish, TR; Kamataki, T; Saul, GS
      The relationship between shellbed type and sequence architecture: examplesfrom Japan and New Zealand

      SEDIMENTARY GEOLOGY
    56. NAKAMURA K; YOKOI T; KODAMA T; INOUE K; NAGASHIMA K; SHIMADA N; SHIMIZU T; KAMATAKI T
      OXIDATION OF HISTAMINE H1 ANTAGONIST MEQUITAZINE IS CATALYZED BY CYTOCHROME-P450 2D6 IN HUMAN LIVER-MICROSOMES

      Naunyn-Schmiedeberg's archives of pharmacology
    57. TAKASUNA K; HAGIWARA T; KAMATAKI T
      INVOLVEMENT OF BETA-GLYCURONIDASE IN INTESTINAL MICROFLORA IN THE INTESTINAL TOXICITY OF THE ANTITUMOR CAMPTOTHECIN DERIVATIVE, IRINOTECAN (CPT-11), IN RATS

      Naunyn-Schmiedeberg's archives of pharmacology
    58. NAKAMURA K; YOKOI T; KODAMA T; INOUE K; NAGASHIMA K; SHIMADA N; SHIMIZU T; KAMATAKI T
      OXIDATION OF HISTAMINE H1 ANTAGONIST MEQUITAZINE IS CATALYZED BY CYTOCHROME-P450 2D6 IN HUMAN LIVER-MICROSOMES

      The Journal of pharmacology and experimental therapeutics
    59. TASAKI T; NAKAMURA A; ITOH S; OHASHI K; YAMAMOTO Y; MASUDA M; IWATA H; KAZUSAKA A; KAMATAKI T; FUJITA S
      EXPRESSION AND CHARACTERIZATION OF DOG CYP2D15 USING BACULOVIRUS EXPRESSION SYSTEM

      Journal of Biochemistry
    60. SUZUKI A; KUSHIDA H; IWATA H; WATANABE M; NOHMI T; FUJITA K; GONZALEZ FJ; KAMATAKI T
      ESTABLISHMENT OF A SALMONELLA TESTER STRAIN HIGHLY SENSITIVE TO MUTAGENIC HETEROCYCLIC AMINES

      Cancer research
    61. ANDO Y; SHIMIZU T; NAKAMURA K; MUSHIRODA T; NAKAGAWA T; KODAMA T; KAMATAKI T
      POTENT AND NONSPECIFIC INHIBITION OF CYTOCHROME-P450 BY JM216, A NEW ORAL PLATINUM AGENT

      British Journal of Cancer
    62. SAKUMA T; HIEDA M; IGARASHI T; OHGIYA S; NAGATA R; NEMOTO N; KAMATAKI T
      MOLECULAR-CLONING AND FUNCTIONAL-ANALYSIS OF CYNOMOLGUS MONKEY CYP1A2

      Biochemical pharmacology
    63. IWATA H; FUJITA K; KUSHIDA H; SUZUKI A; KONNO Y; NAKAMURA K; FUJINO A; KAMATAKI T
      HIGH CATALYTIC ACTIVITY OF HUMAN CYTOCHROME-P450 COEXPRESSED WITH HUMAN NADPH-CYTOCHROME P450 REDUCTASE IN ESCHERICHIA-COLI

      Biochemical pharmacology
    64. YAMADA A; FUJITA K; YOKOI T; MUTO S; SUZUKI A; GONDO Y; KATSUKI M; KAMATAKI T
      IN-VIVO DETECTION OF MUTATIONS INDUCED BY AFLATOXIN B-1 USING HUMAN CYP3A7 HITEC HYBRID MICE/

      Biochemical and biophysical research communications (Print)
    65. TAKAHASHI Y; SUZUKI C; KAMATAKI T
      SILENCING OF CYP1A1 EXPRESSION IN RABBITS BY DNA METHYLATION

      Biochemical and biophysical research communications
    66. NAKURA H; ITOH S; KUSANO H; ISHIZONE H; KAMATAKI T
      OPPOSITE EFFECTS OF ISONIAZID AND FASTING ON THE EXPRESSION OF CYP2E1PROTEIN AND MESSENGER-RNA IN-HOUSE MUSK SHREW (SUNCUS-MURINUS)

      Biochemistry and molecular biology international
    67. TANI H; SAITOH T; KAMIDATE T; KAMATAKI T; WATANABE H
      SELECTIVE SOLUBILIZATION OF MICROSOMAL ELECTRON-TRANSFER PROTEINS WITH ALKYLGLUCOSIDE

      Analytical sciences
    68. FUJITA K; IWATA H; KUSHIDA H; SUZUKI A; NAKAMURA K; KONNO Y; KAMATAKI T
      SIMULTANEOUS EXPRESSION OF HUMAN P450 AND HUMAN NADPH-P450 REDUCTASE IN ESCHERICHIA-COLI - EXTREMELY HIGH-ACTIVITY TO METABOLIZE DRUGS

      The FASEB journal
    69. GILLAM EMJ; WUNSCH RM; UENG YF; SHIMADA T; PARIKH A; KAMATAKI T; GUENGERICH FP
      EXPRESSION OF P450 3A7 IN ESCHERICHIA-COLI - EFFECTS OF 5 MODIFICATION AND CATALYTIC CHARACTERIZATION OF THE RECOMBINANT ENZYME

      The FASEB journal
    70. NAKAYAMA K; SUDO Y; SASAKI Y; IWATA H; KAMATAKI T
      TRANSCRIPTIONAL REGULATION OF CYP3A16 GENE - ANALYSIS BY DIRECT-INJECTION OF DNA INTO MOUSE-LIVER

      The FASEB journal
    71. TAKAHASHI Y; NAKAYAMA K; FUJIIKURIYAMA Y; KAMATAKI T
      NEGATIVE REGULATORS OF CYP1A1 EXPRESSION IN THE LIVER FROM ADULT-RABBITS

      The FASEB journal
    72. ITOH S; ABE Y; KUBO A; OKUDA M; SHIMOJI M; NAKAYAMA K; KAMATAKI T
      ISOLATION OF A PROMOTER REGION IN MOUSE CYTOCHROME-P450 3A (CYP3A16) GENE AND ITS TRANSCRIPTIONAL CONTROL

      Biochimica et biophysica acta, N. Gene structure and expression
    73. SAKUMA T; IGARASHI T; HIEDA M; OHGIYA S; ISOGAI M; NINOMIYA S; NAGATA R; NEMOTO N; KAMATAKI T
      MARMOSET CYP1A2 - PRIMARY STRUCTURE AND CONSTITUTIVE EXPRESSION IN LIVERS

      Carcinogenesis
    74. KASHIYAMA E; YOKOI T; ODOMI M; FUNAE Y; INOUE K; KAMATAKI T
      CYTOCHROME-P450 RESPONSIBLE FOR THE STEREOSELECTIVE S-OXIDATION OF FLOSEQUINAN IN HEPATIC MICROSOMES FROM RATS AND HUMANS

      Drug metabolism and disposition
    75. TATEISHI T; NAKURA H; ASOH M; WATANABE M; TANAKA M; KUMAI T; TAKASHIMA S; IMAOKA S; FUNAE Y; YABUSAKI Y; KAMATAKI T; KOBAYASHI S
      A COMPARISON OF HEPATIC CYTOCHROME-P450 PROTEIN EXPRESSION BETWEEN INFANCY AND POSTINFANCY

      Life sciences
    76. IWATSUBO T; SUZUKI H; SHIMADA N; CHIBA K; ISHIZAKI T; GREEN CE; TYSON CA; YOKOI T; KAMATAKI T; SUGIYAMA Y
      PREDICTION OF IN-VIVO HEPATIC METABOLIC-CLEARANCE OF YM796 FROM IN-VITRO DATA BY USE OF HUMAN LIVER-MICROSOMES AND RECOMBINANT P-450 ISOZYMES

      The Journal of pharmacology and experimental therapeutics
    77. TAKAHASHI Y; NAKAYAMA K; ITOH S; FUJIIKURIYAMA Y; KAMATAKI T
      INHIBITION OF THE TRANSCRIPTION OF CYP1A1 GENE BY THE UPSTREAM STIMULATORY FACTOR-1 IN RABBITS - COMPETITIVE-BINDING OF USF1 WITH AHR-CENTER-DOT-ARNT COMPLEX

      The Journal of biological chemistry
    78. KASE Y; HAYAKAWA T; TOGASHI Y; KAMATAKI T
      RELEVANCE OF IRINOTECAN HYDROCHLORIDE-INDUCED DIARRHEA TO THE LEVEL OF PROSTAGLANDIN E-2 AND WATER-ABSORPTION OF LARGE-INTESTINE IN RATS

      Japanese Journal of Pharmacology
    79. KASE Y; HAYAKAWA T; ABURADA M; KOMATSU Y; KAMATAKI T
      PREVENTIVE EFFECTS OF HANGE-SHASHIN-TO ON IRINOTECAN HYDROCHLORIDE-CAUSED DIARRHEA AND ITS RELEVANCE TO THE COLONIC PROSTAGLANDIN E-2 AND WATER-ABSORPTION IN THE RAT

      Japanese Journal of Pharmacology
    80. LI Y; YOKOI T; KATSUKI M; WANG JS; GROOPMAN JD; KAMATAKI T
      IN-VIVO ACTIVATION OF AFLATOXIN B-1 IN C57BL 6N MICE CARRYING A HUMANFETUS-SPECIFIC CYP3A7 GENE/

      Cancer research
    81. TANI H; SAITOH T; KAMIDATE T; KAMATAKI T; WATANABE H
      POLYMER-INDUCED PHASE-SEPARATION IN AQUEOUS MICELLAR SOLUTIONS OF OCTYL-BETA-D-THIOGLUCOSIDE FOR EXTRACTION OF MEMBRANE-PROTEINS

      Biotechnology and bioengineering
    82. TAKAHASHI Y; NAKAYAMA K; ITOH S; KAMATAKI T
      UPSTREAM STIMULATORY FACTOR-1 (USF1) SUPPRESSES INDUCTION OF CYP1A1 MESSENGER-RNA BY 3-METHYLCHOLANTHRENE (MC) IN HEPG2 CELLS

      Biochemical and biophysical research communications
    83. MORI T; ITOH S; OHGIYA S; ISHIZAKI K; KAMATAKI T
      REGULATION OF CYP1A AND CYP3A MESSENGER-RNAS BY ASCORBIC-ACID IN GUINEA-PIGS

      Archives of biochemistry and biophysics
    84. GILLAM EMJ; WUNSCH RM; UENG YF; SHIMADA T; REILLY PEB; KAMATAKI T; GUENGERICH FP
      EXPRESSION OF CYTOCHROME-P450 3A7 IN ESCHERICHIA-COLI - EFFECTS OF 5'-MODIFICATION AND CATALYTIC CHARACTERIZATION OF RECOMBINANT ENZYME EXPRESSED IN BICISTRONIC FORMAT WITH NADPH-CYTOCHROME P450 REDUCTASE

      Archives of biochemistry and biophysics
    85. KUBO A; ITOH S; ITOH K; KAMATAKI T
      DETERMINATION OF FAD-BINDING DOMAIN IN FLAVIN-CONTAINING MONOOXYGENASE-1 (FMO1)

      Archives of biochemistry and biophysics
    86. OHGIYA S; GODA T; HOSHINO T; KAMATAKI T; ISHIZAKI K
      ESTABLISHMENT OF A NOVEL HOST, HIGH-RED YEAST THAT STABLY EXPRESSES HAMSTER NADPH-CYTOCHROME P450 OXIDOREDUCTASE - USEFULNESS FOR EXAMINATION OF THE FUNCTION OF MAMMALIAN CYTOCHROME-P450

      Archives of biochemistry and biophysics
    87. YANAGIMOTO T; ITOH S; SAWADA M; KAMATAKI T
      MOUSE CYTOCHROME-P450 (CYP3A11) - PREDOMINANT EXPRESSION IN LIVER ANDCAPACITY TO ACTIVATE AFLATOXIN B-1

      Archives of biochemistry and biophysics
    88. IGARASHI T; SAKUMA T; ISOGAI M; NAGATA R; KAMATAKI T
      MARMOSET LIVER CYTOCHROME P450S - STUDY FOR EXPRESSION AND MOLECULAR-CLONING OF THEIR CDNAS

      Archives of biochemistry and biophysics
    89. TOIDE K; ITOH S; NAGASAKA Y; YANAGIMOTO T; KAMATAKI T
      GENE STRUCTURE OF MOUSE CYP3A11 - EVIDENCE FOR AN ENHANCER ELEMENT WITHIN ITS 5'-FLANKING SEQUENCES

      Archives of biochemistry and biophysics
    90. YOKOI T; KOSAKA Y; CHIDA M; CHIBA K; NAKAMURA H; ISHIZAKI T; KINOSHITA M; SATO K; GONZALEZ FJ; KAMATAKI T
      A NEW CYP2D6 ALLELE WITH A 9 BASE INSERTION IN EXON-9 IN A JAPANESE POPULATION ASSOCIATED WITH POOR METABOLIZER PHENOTYPE

      Pharmacogenetics
    91. NAKAMURA K; YOKOI T; INOUE K; SHIMADA N; OHASHI N; KUME T; KAMATAKI T
      CYP2D6 IS THE PRINCIPAL CYTOCHROME-P450 RESPONSIBLE FOR THE METABOLISM OF THE HISTAMINE H-1 ANTAGONIST PROMETHAZINE IN HUMAN LIVER-MICROSOMES

      Pharmacogenetics
    92. NELSON DR; KOYMANS L; KAMATAKI T; STEGEMAN JJ; FEYEREISEN R; WAXMAN DJ; WATERMAN MR; GOTOH O; COON MJ; ESTABROOK RW; GUNSALUS IC; NEBERT DW
      P450 SUPERFAMILY - UPDATE ON NEW SEQUENCES, GENE-MAPPING, ACCESSION NUMBERS AND NOMENCLATURE

      Pharmacogenetics
    93. NAKAGAWA T; SAWADA M; GONZALEZ FJ; YOKOI T; KAMATAKI T
      STABLE EXPRESSION OF HUMAN CYP2E1 IN CHINESE-HAMSTER CELLS - HIGH-SENSITIVITY TO N,N-DIMETHYLNITROSAMINE IN CYTOTOXICITY TESTING

      Mutation research. Section on environmental mutagenesis and related subjects
    94. NAKAJIMA M; YAMAMOTO T; NUNOYA K; YOKOI T; NAGASHIMA K; INOUE K; FUNAE Y; SHIMADA N; KAMATAKI T; KUROIWA Y
      ROLE OF HUMAN CYTOCHROME P4502A6 IN C-OXIDATION OF NICOTINE

      Drug metabolism and disposition
    95. NUNOYA KI; YOKOI T; KIMURA K; KODAMA T; FUNAYAMA M; INOUE K; NAGASHIMA K; FUNAE Y; SHIMADA N; GREEN C; KAMATAKI T
      (-CIS-3,5-DIMETHYL-2-(3-PYRIDYL) THIAZOLIDIN-4-ONE HYDROCHLORIDE (SM-12502) AS A NOVEL SUBSTRATE FOR CYTOCHROME-P450 2A6 IN HUMAN LIVER-MICROSOMES())

      The Journal of pharmacology and experimental therapeutics
    96. NAKAJIMA M; YAMAMOTO T; NUNOYA KI; YOKOI T; NAGASHIMA K; INOUE K; FUNAE Y; SHIMADA N; KAMATAKI T; KUROIWA Y
      CHARACTERIZATION OF CYP2A6 INVOLVED IN 3'-HYDROXYLATION OF COTININE IN HUMAN LIVER-MICROSOMES

      The Journal of pharmacology and experimental therapeutics
    97. SHIMOJI M; ITOH S; TOIDE K; NAKAYAMA K; AIZAWA S; KAMATAKI T
      APPLICATION OF PRIMARY HEPATOCYTES FROM P53-KNOCKOUT MICE FOR STUDIESOF EXPRESSION OF CYP3A

      Journal of Biochemistry
    98. TAKAHASHI Y; NAKAYAMA K; SHIMOJIMA T; ITOH S; KAMATAKI T
      EXPRESSION OF ARYL-HYDROCARBON RECEPTOR (AHR) AND ARYL-HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR (ARNT) IN ADULT-RABBITS KNOWN TO BE NONRESPONSIVE TO CYTOCHROME-P-450 1A1 (CYP1A1) INDUCERS

      European journal of biochemistry
    99. TAKASUNA K; HAGIWARA T; HIROHASHI M; KATO M; NOMURA M; NAGAI E; YOKOI T; KAMATAKI T
      INVOLVEMENT OF BETA-GLUCURONIDASE IN INTESTINAL MICROFLORA IN THE INTESTINAL TOXICITY OF THE ANTITUMOR CAMPTOTHECIN DERIVATIVE IRINOTECAN HYDROCHLORIDE (CPT-11) IN RATS

      Cancer research
    100. LI Y; YOKOI T; SASAKI M; HATTORI K; KATSUKI M; KAMATAKI T
      PERINATAL EXPRESSION AND INDUCIBILITY OF HUMAN CYP3A7 IN C57BL 6N TRANSGENIC MICE/

      Biochemical and biophysical research communications


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 08/08/20 alle ore 09:19:43